Display Settings:

Format

Send to:

Choose Destination
    J Virol. 2009 Jun;83(11):5947-50. Epub 2009 Mar 25.

    Influenza A virus lacking M2 protein as a live attenuated vaccine.

    Source

    Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53706, USA.

    Abstract

    Mutant influenza virus that lacks the transmembrane and cytoplasmic tail domains of M2 (M2 knockout [M2KO]) is attenuated in both cell culture and mice. Here, we examined the potency of M2KO influenza virus as a live attenuated influenza vaccine. M2KO virus grew as efficiently as the wild-type virus in cells stably expressing the wild-type M2, indicating the feasibility of efficient vaccine production. Mice intranasally vaccinated with M2KO virus developed protective immune responses and survived a lethal challenge with the wild-type virus, suggesting that the M2KO virus has potential as a live attenuated vaccine.

    PMID:
    19321619
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2681926
    Free PMC Article

    Images from this publication.See all images (2) Free text

    FIG. 1.
    FIG. 2.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk